Double-blind randomized mullicenter study comparing the efficacy and safety of 10-day to 5-day terlipressin treatment of bleeding esophageal varices

Hepato-Gastroenterology

Volumn 56, Issue 90, 2009, Pages 390-394

  Bruha, Radan ^a,f   Marecek, Zdenek ^e   Prochazka, Vlastimil ^b   Lata, Jan ^c   Spicak, Julius ^d   Ehrmann, Jiri ^b   Kroupa, Radek ^c   Petrtyl, Jaromir ^a   Dolina, Jiri ^c   Taimr, Pavel ^d   Drastich, Pavel ^d   Urbanek, Petr ^e   Vrzalova, Drahomira ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

^d INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^e CENTRAL MILITARY HOSPITAL   (Czech Republic)

^f CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adverse events; Cirrhosis; Hyponatremia; Renal parameters; Terlipressin; Variceal bleeding

Indexed keywords

TERLIPRESSIN;

ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; HYPERTENSION; HYPONATREMIA; LIVER CIRRHOSIS; MALE; MORTALITY; MULTICENTER STUDY; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; TREATMENT DURATION;

DOUBLE-BLIND METHOD; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HUMANS; LYSINE VASOPRESSIN; MALE; MIDDLE AGED; SAFETY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 67649201150     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. D'Amico G, Luca A: Natural history. Clinical-haemody-namic correlations. Prediction of the risk of bleeding. Bail-lieres Clin Gastroenterol. 1997; 11:243-256.
2. Chalasani N, Kahi C, Francois F et al: Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol. 2003; 98:653-659.
3. McCormick PA, O'Keefe C: Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001; 49:682-685.
4. D'Amico G, de Franchis R: Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38:599-612.
5. De Franchis R, Primignani M: Endoscopic treatments for portal hypertension. Sem Liver Dis. 1999; 19:439-455.
6. Banares R, Albillos A, Rincon D et al: Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002; 35:609-615.
7. Laine L, Plana R, Nevens F, Banares R, Patch D, Bosch J: Treatment of the acute bleeding episode. In: De Franchis. Portal Hypertension IV, Proceedings of the fourth Baveno international consensus workshop on methodology of diagnosis and treatment. Oxford: Blackwell Publishing Ltd.; 2006.
8. D'Amico G, Pagliaro L, Bosh J: The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:332-354.
9. Bosh J, Abraldes JG, Groszmann R: Current management of portal hypertension. J Hepatol. 2003; 38(suppl 1):S54-S68.
10. Bruha R., Marecek Z., Spicak J., Hulek P., Lata J., Petrtyl J., Urbanek P., Taimr P., Volfova M., Dite P: Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding. Hepatogastroenterology 2002; 49:1161-1166.
11. Escorsell A, Del Arbol LR, Planas R, Albillos A, Banares R, Cales P, Pateron D, Bernard B, Vinel JP, Bosch J: Multicenter Randomized Controlled Trial of Terlipressin Versus Sclerotherapy in the Treatment of Acute Variceal Bleeding: The TEST Study. Hepatology 2000; 32:471-476.
12. Nevens F: Review article: a critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage. Aliment Pharmacol Ther. 2004; 20(Suppl.3):18-22.
13. Soderlund C, Magnusson I, Torngren S, Lundell L: Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding esophageal varices. A double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol. 1990; 25:622-630.
14. De Franchis R: Portal hypertension III. Proceedings of the third Baveno international consensus workshop of definitions, methodology and therapeutic strategies. London: Blackwell Science Ltd.; 2001.
15. De Franchis R. Portal hypertension IV. Proceedings of the fourth Baveno international consensus workshop. Oxford: Blackwell Publishing Ltd.; 2006.
16. Harewood GC, Baron TH, Song LM: Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding. J Gastroenterol Hepatol. 2006; 21:237-241.
17. Bernard B, Nguen Ke, Opolon P et al: Antibiotic pro-phylaxis for the prevention of bacterial infections in cir-rhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29:1655-1661.
18. Ben Ari Z, Cardin F, McCormick AP et al: A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol. 1999; 31:443-450.
19. Hausinger D: Low grade cerebral edema and the patho-genesis of hepatic encephalopathy in cirrhosis. Hepatology. 2006;43:1187-1190.
20. Angeli P, Wong F, Watson H, Gines P et al: Hypona-tremia in Cirrhosis: Results of a Patient Population Survey. Hepatology 2006; 44:1535-1542.
21. Cordoba J, Gottstein J, Blei AT: Chronic hyponatremia exacerbates amonia-induced brain edema in rats after por-tocaval anastomosis. J Hepatol. 1998; 29:589-594.
22. Moreau R, Durand F, Poynard T et al: Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002; 122: 923-930.
23. Gines P, Guevara M, Arroyo V, Rodes J: Hepatorenal syndrome. Lancet 2003; 362:1819-1827.